NO774359L - Fremgangsmaate ved fremstilling av nye 7-halo-3,20-dioxo-1,4-pregnadiener og -4-pregnener - Google Patents

Fremgangsmaate ved fremstilling av nye 7-halo-3,20-dioxo-1,4-pregnadiener og -4-pregnener

Info

Publication number
NO774359L
NO774359L NO774359A NO774359A NO774359L NO 774359 L NO774359 L NO 774359L NO 774359 A NO774359 A NO 774359A NO 774359 A NO774359 A NO 774359A NO 774359 L NO774359 L NO 774359L
Authority
NO
Norway
Prior art keywords
pregnes
pregna
dienes
dioxo
halo
Prior art date
Application number
NO774359A
Other languages
English (en)
Other versions
NO151826C (no
NO151826B (no
Inventor
Michael Green
Ho-Jane Shue
Elliot L Shapiro
Margaret A Gentles
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/753,257 external-priority patent/US4076708A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of NO774359L publication Critical patent/NO774359L/no
Publication of NO151826B publication Critical patent/NO151826B/no
Publication of NO151826C publication Critical patent/NO151826C/no

Links

Classifications

    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
    • E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
    • E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
    • E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
    • E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Engineering & Computer Science (AREA)
  • Civil Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Structural Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO774359A 1976-12-22 1977-12-19 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 7-klor- eller brom-3,20-dioxo-1,4-pregnadiener og-4-pregnener NO151826C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75325676A 1976-12-22 1976-12-22
US05/753,257 US4076708A (en) 1976-12-22 1976-12-22 Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Publications (3)

Publication Number Publication Date
NO774359L true NO774359L (no) 1978-06-23
NO151826B NO151826B (no) 1985-03-04
NO151826C NO151826C (no) 1985-06-12

Family

ID=27115720

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774359A NO151826C (no) 1976-12-22 1977-12-19 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 7-klor- eller brom-3,20-dioxo-1,4-pregnadiener og-4-pregnener

Country Status (20)

Country Link
JP (1) JPS604198B2 (no)
AR (1) AR226806A1 (no)
AT (2) AT373269B (no)
BE (1) BE862089A (no)
DE (1) DE2756550C2 (no)
DK (1) DK153494C (no)
FI (1) FI63947C (no)
FR (1) FR2384793A1 (no)
GB (1) GB1575983A (no)
HK (1) HK584A (no)
HU (1) HU179784B (no)
IE (1) IE45950B1 (no)
IL (1) IL53636A (no)
MY (1) MY8500082A (no)
NL (1) NL180479C (no)
NO (1) NO151826C (no)
NZ (1) NZ186031A (no)
PT (1) PT67432B (no)
SE (1) SE429865B (no)
SG (1) SG58683G (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109680036A (zh) 2017-10-02 2019-04-26 爱科来株式会社 糖化蛋白质的测定

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429926A (en) * 1964-05-25 1969-02-25 Squibb & Sons Inc 7-halo and 6-halo,6-dehydro a-norprogesterones

Also Published As

Publication number Publication date
DK153494B (da) 1988-07-18
AR226806A1 (es) 1982-08-31
AT377566B (de) 1985-04-10
FI63947C (fi) 1983-09-12
IL53636A0 (en) 1978-03-10
NO151826C (no) 1985-06-12
FI773825A (fi) 1978-06-23
NL7714056A (nl) 1978-06-26
NL180479C (nl) 1987-03-02
SE7714538L (sv) 1978-06-23
DK153494C (da) 1989-02-20
SE429865B (sv) 1983-10-03
ATA575980A (de) 1982-04-15
SG58683G (en) 1985-01-11
DE2756550A1 (de) 1978-07-06
DK569977A (da) 1978-09-28
FR2384793A1 (fr) 1978-10-20
IL53636A (en) 1983-05-15
JPS5379850A (en) 1978-07-14
PT67432A (en) 1978-01-01
MY8500082A (en) 1985-12-31
HK584A (en) 1984-01-13
NL180479B (nl) 1986-10-01
JPS604198B2 (ja) 1985-02-01
HU179784B (en) 1982-12-28
AT373269B (de) 1984-01-10
FR2384793B1 (no) 1981-11-13
BE862089A (fr) 1978-06-20
IE45950L (en) 1978-06-22
DE2756550C2 (de) 1986-10-16
FI63947B (fi) 1983-05-31
NO151826B (no) 1985-03-04
PT67432B (en) 1979-05-23
ATA909477A (de) 1983-05-15
GB1575983A (en) 1980-10-01
IE45950B1 (en) 1983-01-12
NZ186031A (en) 1984-07-31

Similar Documents

Publication Publication Date Title
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
NO773035L (no) Fremgangsmaate ved fremstilling av polymerer
NO790661L (no) Fremgangsmaate for fremstilling av nye, resorberbare farmasoeytiske preparater
IT7849473A0 (it) Procedimento per preparare 1,2 polibutadiene
NO783442L (no) Fremgangsmaate ved fremstilling av nye fenylethanolaminderivater
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
RO80379A (ro) Procedeu pentru prepararea unor oentapeptide
NO784281L (no) Fremgangsmaate til fremstilling av nye 2alfa-cyano-3-okso-steroider
NO780071L (no) Nye oksazolidinderivater.
NO783964L (no) Fremgangsmaate ved fremstilling av nye prostacyclinderivater
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
NO773009L (no) Fremgangsmaate til fremstilling av nye derivater av perhydro-aza-heterocykler
NO783958L (no) Fremgangsmaate for fremstilling av nye indolokinolizidiner
NO772997L (no) Fremgangsmaate til fremstilling av nye benzopyranderivater
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
NO831790L (no) Nye pyrido-indol-derivater.
NO773472L (no) Fremgangsmaate ved fremstilling av nye piperidylidenderivater
SE435381B (sv) Forfarande for framstellning av hypotensiva 2-(4-furoylpiperazin-1-yl)-4-amino-6,7-dimetoxikinazolin
IT1065800B (it) Procedimento per preparare trimetil-3,5,5 cicloesen-2 dione-1,4
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
NO802403L (no) Fremgangsmaate ved fremstilling av nye 10-halogen-e-homo-eburnanderivater.
NO813180L (no) Fremgangsmaate for fremstilling av nye benzodiazepinderivater.
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
NO774294L (no) Fremgangsmaate ved fremstilling av nye piperazinderivater
NO782042L (no) Fremgangsmaate ved fremstilling av nye pyridazinylhydraziner.